Agenda Information
The University of Texas M. D. Anderson Cancer Center and
M. D. Anderson Physicians Network
Continuing Medical Education
July 11–14, 2009
Fifth Annual Symposium:
Update on Personalized Medicine and Multidisciplinary Cancer Therapy
July 11–14, 2009 | |
Update on Personalized Medicine and Multidisciplinary Cancer Therapy | |
|
|
Saturday, July 11, 2009 | |
|
|
Gastrointestinal Cancers - Program Co-Chair: James L. Abbruzzese, MD | |
|
|
6:30-7:00 a.m. | Continental Breakfast/Registration |
|
|
7:00-7:15 | Introduction and Welcome - Waun K. Hong, MD, William J. Simeone, Jr., MHA |
|
|
7:15-7:55 | Keynote Speaker - James L. Abbruzzese, MD |
|
|
7:55-8:20 | Contemporary Management of Advanced Colorectal Cancer |
|
|
8:20-8:45 | Surgical Management of Colorectal Hepatic Metastases |
|
|
8:45-9:10 | Novel Targets and Innovative Clinical Trials Design for Advanced Colorectal Cancer |
|
|
9:10-9:20 | Break |
|
|
9:20-9:45 | Update on Neoadjuvant and Adjuvant Therapy in the Treatment of Pancreatic Cancer |
|
|
9:45-10:10 | Management of Borderline Resectable Pancreatic Cancer |
|
|
10:10-10:35 | The Role of Proton Beam Therapy in the Treatment of Gastrointestinal Cancers |
|
|
10:35-10:45 | Break |
|
|
10:45-11:15 | Challenging Gastrointestinal Cancer Cases Presentation and Interactive Audience Participation |
|
|
|
|
11:15-11:25 | Break and Pick Up Box Lunch |
|
|
Gynecologic Cancers - Program Co-Chair: David M. Gershenson, MD | |
|
|
11:25-11:30 | Introduction - David M. Gershenson, MD |
|
|
11:30-11:55 | Contemporary Management of Primary Epithelial Ovarian Cancer |
|
|
11:55-12:20 p.m. | Update on Management of Recurrent Epithelial Ovarian Cancer |
|
|
12:20-12:45 | Updates in the Surgical Management of Advanced Ovarian Cancer |
|
|
12:45-1:10 | New Developments in Therapy for Uncommon Ovarian Tumors |
|
|
1:10-1:35 | Contemporary Management of Cervical and Uterine Malignancies |
|
|
1:35-2:00 | Challenging Gynecologic Oncology Cases Presentation and Interactive Audience Participation |
|
|
2:00 | Adjourn |
|
|
6:30-8:30 p.m. | Welcome Reception - Terrace |
|
|
Sunday, July 12, 2009 | |
|
|
Genitourinary Cancers - Program Co-Chair: Richard J. Babaian, MD | |
|
|
6:45-7:15 a.m. | Continental Breakfast/Registration |
|
|
7 :15-7:20 | Introduction - Richard J. Babaian, MD |
|
|
Prostate Cancer | |
|
|
7:20-7:40 | Technical and Treatment Parameters for IMRT and Brachytherapy |
|
|
7:40-8:00 | Proton Therapy: Is It Worth It? |
|
|
8:00- 8:15 | Evaluation and Treatment Considerations for Rising PSA Following Definitive Therapy |
|
|
8:15-8:30 | New Frontiers in the Management of Metastatic Prostate Cancer: Are We Making Progress? |
|
|
8:30-8:45 | Break |
|
|
Testicular Cancer | |
|
|
8:45-9:10 | Current Approach to Management of Stage I Testicular Cancer: Surgical and Medical Perspective |
|
|
9:10-9:30 | Therapeutic Strategies for Metastatic Testicular Cancer |
|
|
Bladder Cancer | |
|
|
9:30-9:50 | Is There a Role for Neoadjuvant or Adjuvant Therapy for High Risk Disease? |
|
|
9:50-10:10 | Update on the Treatment of Metastatic Bladder Cancer |
|
|
10:10-10:25 | Break |
|
|
Renal Cell Cancer | |
|
|
10:25-10:45 | Targeted Therapy Before or After Surgery |
|
|
10:45-11:15 | Challenging Genitourinary Cases Presentation and Interactive Audience Participation |
|
|
11:15-11:30 | Break and Pick Up Box Lunch |
|
|
Lymphoma Program - Program Co-Chair: Peter McLaughlin, MD | |
|
|
1 1:30-11:35 | Introduction - Peter McLaughlin, MD |
|
|
11:35-11:45 | Follicular Lymphoma: Introduction |
|
|
11:45-12:05 p.m. | Follicular Lymphoma: Rethinking Vaccine Strategies |
|
|
12:05-12:15 | Diffuse Large B-cell Lymphoma: Background |
|
|
12:15-12:35 | Diffuse Large B-cell Lymphoma: New Therapeutic Targets |
|
|
12:35-1:00 | Current Management of Mantle Cell Lymphoma |
|
|
1:00-1:30 | Stem Cell Transplant: The Graft Versus Lymphoma Effect |
|
|
1:30-2:00 | Challenging Lymphoma Cases Presentation and Interactive Audience Participation |
|
|
2:00 | Adjourn |
|
|
Monday, July 13, 2009 | |
|
|
Thoracic Cancers - Program Co-Chair: Daniel D. Karp, MD | |
|
|
6:45-7:15 a.m. | Continental Breakfast/Registration |
|
|
7:15-7:20 | Introduction - Daniel D. Karp, MD |
|
|
7:20-7:50 | Enhancing the Staging System: Prognostic Models and Factors Associated with Long-Term Survival |
|
|
7:50-8:20 | Imaging Studies: The Foundation of Individualized Lung Cancer Treatment |
|
|
8:20-8:50 | Preserving Lung Function with Advanced Radiation Techniques |
|
|
8:50-9:20 | New Strategies for Surgical Management Curative Tactics for Regionally Advanced and Oligometastatic Disease |
|
|
9:20 -9:35 | Break |
|
|
9:35-10:05 | Genomic Determinants of Response in Advanced Lung Cancer |
|
|
10:05-10:35 | Changing Paradigms in Advanced Non-Small Cell Lung Cancer: How Can We Tailor Patient Therapy? |
|
|
10:35-11:15 | Challenging Thoracic Cases Presentation and Interactive Audience Participation |
|
|
11:15-11:30 | Break and Pick Up Box Lunch |
|
|
Head and Neck Cancers - Program Co-Chair: Bonnie S. Glisson, MD | |
|
|
11:30-11:35 | Introduction - Bonnie S. Glisson, MD |
|
|
11:35-12:05 p.m. | HPV as a Predictive/Prognostic Factor in Patients Treated With Sequential Chemoradiation: The TAX 324 Experience |
|
|
12:05-12:35 | Radiation and Chemoradiation for Patients With Advanced Head And Neck Cancer: Integration of Personalized Approaches |
|
|
12:35-1:00 | Chemotherapy as Definitive Treatment for Larynx Cancer: The Contribution of Gene Expression Profiling to Prognostication and Prediction |
|
|
1:00-1:30 | Emerging Concepts in Protein Profiling of Head and Neck Cancer: Patients, Cell Lines and Their Intersection |
|
|
1:30-2:00 | Challenging Head and Neck Cases Presentation and Interactive Audience Participation |
|
|
2:00-3:00 | Meet the Professors - All Faculty |
|
|
3:00 | Adjourn |
|
|
Tuesday, July 14, 2009 | |
|
|
Breast Cancer - Program Co-Chair: Kelly K. Hunt, MD | |
|
|
6:45-7:15 a.m. | Continental Breakfast/Registration |
|
|
7 :15-7:20 | Introduction - Kelly K. Hunt, MD |
|
|
7:20-7:50 | Keynote Speaker - Jay R. Harris, MD |
|
|
7:50-8:15 | Diagnostic Work-Up of the Patient With a Breast Complaint |
|
|
8:15-8:40 | What Your Pathology Reports Should Say and How to Interpret Them |
|
|
8:40-9:05 | Improving Local-Regional Control Impacts Survival |
|
|
9:05-9:20 | Break |
|
|
9:20-9:45 | Genetic Testing: When Do We Test and How Do We Counsel Our Patients? |
|
|
9:45-10:10 | Nipple Sparing Mastectomy: When Is It Appropriate to Offer This to Our Patients? |
|
|
10:10-10:35 | New Agents in Systemic Therapy for Early Stage Breast Cancer |
|
|
10:35-10:45 | Break |
|
|
10:45-11:10 | MRI of the Breast: Who Benefits and How Do We Use It in Practice? |
|
|
11:10-11:35 | Evaluation of Micrometastases: How Do We Use the Information Clinically? |
|
|
11:35-Noon | Is It Still Important to Perform Lymph Node Dissection on Patients With a Positive Sentinel Node? |
|
|
Noon-12:15 p.m. | Break and Pick Up Box Lunch |
|
|
12:15-12:40 | Prognostic and Predictive Markers in Breast Cancer: How Do We Use Them Clinically? |
|
|
12:40-1:05 | Partial Breast Irradiation: Who is a Candidate and How Do We Use It in Practice? |
|
|
1:05-1:30 | Cancer Prevention Strategies in Our Breast Cancer Population |
|
|
1:30-2:00 | Challenging Breast Cancer Cases Presentation and Interactive Audience Participation |
|
|
2:00 | Adjourn |
The University of Texas M. D. Anderson Cancer Center has implemented a process whereby everyone who is in a position to control the content of an educational activity must disclose all relevant financial relationships with any commercial interest that could potentially affect the information presented. M. D. Anderson also requires that all
faculty disclose any unlabeled use or investigational use (not yet approved for any purpose) of pharmaceutical and medical device products. Specific disclosure will be made to the participants prior to the educational activity.
Agendas are subject to change because we are always striving to improve the quality of your educational experience. M. D. Anderson may substitute faculty with comparable expertise on rare occasions necessitated by illness, schedule conflicts, and so forth.
Photographing, audio taping and videotaping are prohibited.

